RIPK2 and Crohn disease: Mutations in ATG16L1, linked to Crohn’s disease, interfere with the interaction between NOD2 and RIPK2, resulting in the suppression of RIPK2 signaling and heightened inflammatory responses (Sorbara et al., 2013).